Collaboration for AIDS Vaccine Discovery (CAVD) United States of America (USA)
Research
Date range: 1 December 2022 - 30 November 2023
Research collaboration: Collaboration for AIDS Vaccine Discovery (CAVD) is a research collaboration whose article contributions are accrued to its participating partner institutions.
Relationships
Partner Institutions
Collaboration for AIDS Vaccine Discovery (CAVD) is a research collaboration whose article contributions are accrued to its participating partner institutions below.
- Aaron Diamond AIDS Research Center (ADARC), CU
- Albert Einstein College of Medicine (Einstein)
- Arizona State University (ASU)
- Atreca, Inc.
- Batavia Biosciences B.V.
- Baylor Scott & White Health
- Beth Israel Deaconess Medical Center (BIDMC)
- Blood Systems Research Institute (BSRI)
- Boston Children's Hospital (BCH)
- Brigham and Women's Hospital (BWH)
- CHU Henri-Mondor
- California Institute of Technology (Caltech)
- Case Western Reserve University (CWRU)
- Charité - University Medicine Berlin
- Children's Hospital of Philadelphia (CHOP)
- Dana-Farber Cancer Institute (DFCI)
- Dartmouth College
- Duke University
- Emory University
- EuroVacc Foundation, Switzerland
- Fred Hutchinson Cancer Research Center (FHCRC)
- German Primate Center - Leibniz Institute for Primate Research (DPZ)
- GlaxoSmithKline USA
- Harvard University
- Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF)
- IPPOX Foundation
- Icahn School of Medicine at Mount Sinai (ISMMS), MSHS
- Imperial College London (ICL)
- Infectious Disease Research Institute (IDRI)
- Institute for Research in Biomedicine (IRB Barcelona), BIST
- International AIDS Vaccine Initiative (IAVI)
- LabKey Corporation
- Leiden University Medical Center (LUMC)
- Los Alamos National Laboratory (LANL)
- Loyola University Chicago (LUC)
- Massachusetts Institute of Technology (MIT)
- Merck & Co., Inc.
- Montreal General Hospital (MGH)
- Mymetics S.A.
- NIH NIAID Vaccine Research Center (VRC)
- NIH National Institute of Allergy and Infectious Diseases (NIAID)
- National Health Laboratory Service (NHLS)
- National Institute for Biological Standards and Control (NIBSC)
- National Institute for Health and Medical Research (INSERM)
- National Institutes of Health (NIH)
- New Mexico Consortium (NMC)
- Northwestern University (NU)
- Oregon Health and Science University (OHSU)
- Profectus Biosciences, Inc.
- Ruhr University Bochum (RUB)
- Sanofi Pasteur
- Scripps Research
- South African National Blood Service (SANBS)
- Southern African Research and Innovation Management Association (SARIMA)
- Spanish National Research Council (CSIC)
- TaiMed Biologics Inc.
- Texas Biomedical Research Institute (Texas Biomed)
- The Rockefeller University
- The University of Alabama at Birmingham (UAB)
- The University of Georgia (UGA)
- The University of Kansas (KU)
- The University of North Carolina at Chapel Hill (UNC)
- The University of Utah (Utah)
- Tulane University
- U.S. Army Medical Research and Development Command (USAMRDC)
- University Hospital of Lausanne (CHUV), UNIL
- University of California, Davis (UC Davis)
- University of California, San Diego (UC San Diego)
- University of California, San Francisco (UCSF)
- University of Cambridge
- University of Cape Town (UCT)
- University of KwaZulu-Natal (UKZN)
- University of Maryland, Baltimore (UMB)
- University of Massachusetts Amherst (UMass Amherst)
- University of Milan (UNIMI)
- University of Minnesota Twin Cities (UMTC)
- University of Montreal (UdeM)
- University of Oxford
- University of Pennsylvania (Penn)
- University of Pittsburgh (Pitt)
- University of Regensburg (UR)
- University of Washington (UW)
- Vaccine and Gene Therapy Institute of Florida (VGTI Florida)
- WHO Tropical Diseases Research Center (TDRC)